Journal
CYTOKINE & GROWTH FACTOR REVIEWS
Volume 17, Issue 1-2, Pages 19-27Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.cytogfr.2005.09.008
Keywords
Smad3; TGF-beta; EMT; fibrosis; metastasis
Categories
Ask authors/readers for more resources
Smads2 and 3 transduce signals of TGF-beta from the cell surface to the nucleus. We used mice with a targeted deletion of Smad3 to study the specific contributions of this signaling pathway to pathogenic effects of TGF-beta. Focusing on models involving epithelial-to-mesenchymal transition (EMT), including injury to the lens and retina of the eye and to the kidney, we have found that loss of Smad3 blocks EMT and attenuates development of fibrotic sequelae. Smad3 also plays a critical role in both the tumor suppressor and pro-metastatic effects of TGF-beta in carcinogenesis. These observations suggest that development of small molecule inhibitors of Smad3 might have clinical application in treatment of fibrotic diseases as well as late stage cancers. (c) 2005 Published by Elsevier Ltd.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available